Cargando…
The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management
Irritable bowel syndrome (IBS) has a global prevalence of around 4.1% and is associated with a low quality of life and increased healthcare costs. Current guidelines recommend that IBS is diagnosed using the symptom-based Rome IV criteria. Despite this, when patients seek medical attention, they are...
Autores principales: | Vulpoi, Radu Alexandru, Luca, Mihaela, Ciobanu, Adrian, Olteanu, Andrei, Bărboi, Oana, Iov, Diana-Elena, Nichita, Loredana, Ciortescu, Irina, Cijevschi Prelipcean, Cristina, Ștefănescu, Gabriela, Mihai, Cătălina, Drug, Vasile Liviu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648815/ https://www.ncbi.nlm.nih.gov/pubmed/37958232 http://dx.doi.org/10.3390/diagnostics13213336 |
Ejemplares similares
-
Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
por: Jucan, Alina Ecaterina, et al.
Publicado: (2023) -
Artificial Intelligence in Digestive Endoscopy—Where Are We and Where Are We Going?
por: Vulpoi, Radu-Alexandru, et al.
Publicado: (2022) -
Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation—Randomized Case-Control Study
por: Bărboi, Oana-Bogdana, et al.
Publicado: (2022) -
The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases
por: Palade, Codrina-Madalina, et al.
Publicado: (2022) -
Pepsin and the Lung—Exploring the Relationship between Micro-Aspiration and Respiratory Manifestations of Gastroesophageal Reflux Disease
por: Iov, Diana-Elena, et al.
Publicado: (2022)